- Home
- SNDX vs SEDG Comparison
SNDX vs SEDG Comparison
Compare SNDX & SEDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- SEDG
- Stock Information
- Founded
- SNDX 2005
- SEDG 2006
- Country
- SNDX United States
- SEDG Israel
- Employees
- SNDX N/A
- SEDG N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- SEDG Semiconductors
- Sector
- SNDX Health Care
- SEDG Technology
- Exchange
- SNDX Nasdaq
- SEDG Nasdaq
- Market Cap
- SNDX 1.3B
- SEDG 1.5B
- IPO Year
- SNDX 2016
- SEDG 2015
- Fundamental
- Price
- SNDX $13.51
- SEDG $37.84
- Analyst Decision
- SNDX Strong Buy
- SEDG Sell
- Analyst Count
- SNDX 11
- SEDG 20
- Target Price
- SNDX $38.55
- SEDG $21.71
- AVG Volume (30 Days)
- SNDX 3.3M
- SEDG 3.4M
- Earning Date
- SNDX 11-03-2025
- SEDG 11-05-2025
- Dividend Yield
- SNDX N/A
- SEDG N/A
- EPS Growth
- SNDX N/A
- SEDG N/A
- EPS
- SNDX N/A
- SEDG N/A
- Revenue
- SNDX $77,933,000.00
- SEDG $940,561,000.00
- Revenue This Year
- SNDX $629.90
- SEDG $34.78
- Revenue Next Year
- SNDX $114.74
- SEDG $16.05
- P/E Ratio
- SNDX N/A
- SEDG N/A
- Revenue Growth
- SNDX 2126.66
- SEDG N/A
- 52 Week Low
- SNDX $8.58
- SEDG $10.24
- 52 Week High
- SNDX $22.50
- SEDG $41.92
- Technical
- Relative Strength Index (RSI)
- SNDX 36.63
- SEDG 51.54
- Support Level
- SNDX $13.00
- SEDG $35.81
- Resistance Level
- SNDX $15.79
- SEDG $41.73
- Average True Range (ATR)
- SNDX 1.10
- SEDG 3.03
- MACD
- SNDX -0.26
- SEDG -0.17
- Stochastic Oscillator
- SNDX 13.82
- SEDG 47.01
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.
About SEDG SolarEdge Technologies Inc.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.